These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Androgens in polycystic ovary syndrome: the role of exercise and diet. Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064 [TBL] [Abstract][Full Text] [Related]
23. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin. Svendsen PF; Nilas L; Madsbad S; Holst JJ Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579 [TBL] [Abstract][Full Text] [Related]
24. [Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance]. Tao MF; Zhu JP; Zhou J; Lu W; Qin W; Teng YC; Jia WP Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):659-63. PubMed ID: 19595057 [TBL] [Abstract][Full Text] [Related]
25. Impaired cardiopulmonary parameters in young women with polycystic ovary syndrome. Orio F; Palomba S; Giallauria F; Colao A; Vigorito C Clin Endocrinol (Oxf); 2007 Jan; 66(1):152-3. PubMed ID: 17201818 [No Abstract] [Full Text] [Related]
27. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome. Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636 [TBL] [Abstract][Full Text] [Related]
28. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498 [TBL] [Abstract][Full Text] [Related]
29. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters. Mitkov M; Pehlivanov B; Orbetzova M Gynecol Endocrinol; 2008 Nov; 24(11):625-30. PubMed ID: 19031219 [TBL] [Abstract][Full Text] [Related]
30. Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy. Diamanti-Kandarakis E; Economou FN; Livadas S; Tantalaki E; Piperi C; Papavassiliou AG; Panidis D Kidney Blood Press Res; 2009; 32(1):24-31. PubMed ID: 19212122 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome. Espinós-Gómez JJ; Corcoy R; Calaf J Gynecol Endocrinol; 2009 Mar; 25(3):199-204. PubMed ID: 19347711 [TBL] [Abstract][Full Text] [Related]
32. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts? Chang AY; Wild RA Semin Reprod Med; 2009 Jul; 27(4):299-305. PubMed ID: 19530063 [TBL] [Abstract][Full Text] [Related]
33. Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome. Christopoulos P; Mastorakos G; Gazouli M; Panidis D; Deligeoroglou E; Katsikis I; Papadias K; Diamandi-Kandarakis E; Creatsas G Gynecol Endocrinol; 2008 Sep; 24(9):486-90. PubMed ID: 18958766 [TBL] [Abstract][Full Text] [Related]
34. Puberty and ovarian function in girls with type 1 diabetes mellitus. Codner E; Cassorla F Horm Res; 2009 Jan; 71(1):12-21. PubMed ID: 19039232 [TBL] [Abstract][Full Text] [Related]
35. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome. Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710 [TBL] [Abstract][Full Text] [Related]
36. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance. Gen R; Akbay E; Muslu N; Sezer K; Cayan F Gynecol Endocrinol; 2009 Apr; 25(4):241-5. PubMed ID: 19408173 [TBL] [Abstract][Full Text] [Related]
37. Ectopic fat deposition and the metabolic syndrome in obese children and adolescents. Cali AM; Caprio S Horm Res; 2009 Jan; 71 Suppl 1():2-7. PubMed ID: 19153496 [TBL] [Abstract][Full Text] [Related]
38. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. Tan BK; Adya R; Chen J; Farhatullah S; Heutling D; Mitchell D; Lehnert H; Randeva HS Cardiovasc Res; 2009 Aug; 83(3):566-74. PubMed ID: 19414528 [TBL] [Abstract][Full Text] [Related]
39. Use of metformin in polycystic ovary syndrome. Mathur R; Alexander CJ; Yano J; Trivax B; Azziz R Am J Obstet Gynecol; 2008 Dec; 199(6):596-609. PubMed ID: 19084097 [TBL] [Abstract][Full Text] [Related]
40. Evidence for insulin resistance in Indian patients with non-insulin dependent diabetes in the young. Jialal I; Naidoo C; Rajput M; Joubert SM Horm Metab Res; 1984 Jul; 16(7):377-8. PubMed ID: 6489923 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]